Rigel Pharmaceuticals Inc
RIGL·Stocks·Pharmaceuticals Major·United States·Nasdaq·USD
Price
$47.46
Today
-1.4%
YTD
+12.5%
About
Rigel Pharmaceuticals is a biotechnology company operating internationally. It discovers and develops small molecule drugs to treat rare diseases, cancer, and immune and hematologic disorders. The company was founded in 1996 and has headquarters in South San Francisco, California. It is assigned the ticker RIGL on the NASDAQ GS stock market.Ensure you don't miss the best time to invest in RIGL stock by adding it to your eToro watchlist.
Price chart
Closing price history for RIGL (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)2.27
P/S (TTM)2.79
P/B (TTM)1.97
Market cap$787.26M
Cap tierSmall-cap
Industry avg P/E-43.35
Profitability
Gross margin93.39%
EBIT margin41.56%
Net margin14.71%
ROE174.08%
ROA107.04%
Earnings & Revenue
Revenue (TTM)$299.77M
Revenue growth (1Y)+47.6%
EPS (TTM)$18.72
Free cash flow$79.27M
Total debt$45.72M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.30
Employees174
Next earnings3 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.